Results showed that out of all five mutations, patients with one specific mutation, MKK7 p.Glu116Lys polymorphism, displayed lung cancer metastasis at a significantly higher rate than all other mutations (Table 1) (Qiu et al., 2016). This evidence concerns the gene MAP2K7 and lung cancer.